精神障碍者不明原因猝死现状及鉴识进展

doi:10.3969/j.issn.1671-2072.2024.02.006

摘要/Abstract

摘要：

精神障碍者猝死风险较普通人群显著增加，同时这类死亡常受精神药物、外伤等多重复杂因素干扰，死亡原因分析极具挑战性。精神障碍者不明原因猝死由于缺乏科学的死因解释及死后精准鉴识策略，一直是司法鉴定的研究难点。近年来，随着解剖学、毒理学和遗传学等方面的研究深入，国内外已对精神障碍者不明原因猝死有了更深的认识。基于国内外相关文献，从解剖学、毒理学和遗传学等角度介绍精神障碍者不明原因猝死的研究现状与猝死机制，并凝练相关鉴识进展，以期提高对相关案件的法医学认识，供法医学鉴定参考。

关键词: 法医病理学, 精神障碍者, 不明原因猝死, 抗精神病药, 死因鉴识

Abstract: The risk of sudden death in individuals with mental disorders is significantly higher than that in the general population. Such death cases are often interfered by multiple complex factors such as psychotropic drugs and trauma,which poses great identification challenges. The sudden unexplained death in individuals with mental disorders has always been a difficult task in forensic appraisal due to the lack of scientific and reasonable explanations for the cause of death and precise identification strategies after death. In recent years, with the in-depth researches into anatomy,toxicology and genetics, there has been a deeper understanding of this type of sudden death. This review aims to gather domestic and foreign literature, and introduces the current research status and mechanisms of sudden unexplained death in individuals with mental disorders from perspectives of anatomy, toxicology and genetics, as well as summarizes the forensic appraisal progress, in order to improve the forensic understanding of relevant cases and provide reference for forensic appraisal.

Key words: forensic pathology, individuals with mental disorders, sudden unexplained death, antipsychotics, cause of
death identification

中图分类号:

李立亮. 精神障碍者不明原因猝死现状及鉴识进展[J]. 中国司法鉴定, 2024(2): 47-54.

LI Liliang. Current Status and Forensic Appraisal Progress of Sudden Unexplained Death in Individuals with Mental Disorders[J]. Chinese Journal of Forensic Sciences, 2024(2): 47-54.

参考文献

[1] 国家卫生健康委员会. 中国卫生健康统计年鉴（2022）[M]. 北京：中国协和医科大学出版社，2022： 409.
[2] LI X，WEI N，SONG J，et al. The global burden of schizophrenia and the impact of urbanization during 1990-2019： An analysis of the global burden of disease study 2019[J]. Environmental Research，2023，232：116305.
[3] SUN D M，LI L L，ZHANG X，et al. Causes of sudden unexpected death in schizophrenia patients： A forensic autopsy population study[J]. The American Journal of Forensic Medicine and Pathology，2019，40（4）： 312-317.
[4] RISGAARD B，WAAGSTEIN K，WINKEL B G，et al. Sudden cardiac death in young adults with previous hospital-based psychiatric inpatient and outpatient treatment： a nationwide cohort study from Denmark[J]. The Journal of Clinical Psychiatry，2015，76（9）： e1122-e1129.
[5] MANU P，KANE J M，CORRELL C U. Sudden deaths in psychiatric patients[J]. Journal of Clinical Psychiatry，2011，72（7）： 936-941.
[6] SWEETING J，DUFLOU J，SEMSARIAN C. Postmortem analysis of cardiovascular deaths in schizophrenia： a 10-year review[J]. Schizophrenia Research，2013，150（2/3）： 398-403.
[7] IFTENI P，CORRELL C U，BURTEA V，et al. Sudden unexpected death in schizophrenia： autopsy findings in psychiatric inpatients[J]. Schizophrenia Research，2014，155（1/2/3）： 72-76.
[8] CHEN Y，ZHANG F，YAN Y，et al. Sudden cardiac death in schizophrenia during hospitalization：An autopsy-based study[J]. Frontiers in Psychiatry，2022，13： 933025.

[9] WANG S Y，HE M，ANDERSEN J，et al. Sudden unexplained death in schizophrenia patients： An autopsy-based comparative study from China[J]. Asian Journal of Psychiatry，2023，79： 103314.

[10] 王韵怡，殷坤，毛丹蜜，等. 84例死亡精神病患者的法医病理学分析[J]. 热带医学杂志，2022，22（4）： 507-512.
[11] 叶星，史程，沈忆文，等. 24例长期服用精神类药物致猝死的法医学分析[J]. 法医学杂志，2018，34（6）： 644-647.
[12] WU X D，XIA L，YANG Y T，et al. Mortality among psychiatric inpatients in China： A national survey[J]. Asian Journal of Psychiatry，2022，77： 103262.
[13] DE HERT M，DETRAUX J，VAN WINKEL R，et al. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs[J]. Nature Reviews Endocrinology，2011，8（2）： 114-126.
[14] 张有友，刘良，朱江涛，等. 常见抗精神病药物心血管毒性的研究进展[J]. 中国法医学杂志，2020，35（1）： 60-63.
[15] MUESER K T，MCGURK S R. Schizophrenia[J]. Lancet，2004，363（9426）： 2063-2072.
[16] MCCUTCHEON R A，REIS M T，HOWES O D. Schizo-phrenia—an overview[J]. JAMA Psychiatry，2020，77（2）： 201-210.
[17] RAY W A，CHUNG C P，MURRAY K T，et al. Atypical antipsychotic drugs and the risk of sudden cardiac death[J]. The New England Journal of Medicine，2009，360（3）： 225-235.
[18] REDFERN W S，CARLSSON L，DAVIS A S，et al. Relationships between preclinical cardiac electrophysiology，clinical QT interval prolongation and torsade de pointes for a broad range of drugs： evidence for a provisional safety margin in drug development[J]. Cardiovascular Research，2003，58（1）： 32-45.
[19] LEE H J，CHOI J S，CHOI B H，et al. Inhibition of cloned hERG potassium channels by risperidone and paliperi-done[J]. Naunyn-Schmiedeberg's Archives Pharmacology，2017，390（6）： 633-642.
[20] MORISSETTE P，HREICHE R，MALLET L，et al. Olanzapine prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current[J]. Journal of Psychopharmacology，2007，21（7）： 735-741.
[21] SUESSBRICH H，SCHONHERR R，HEINEMANN S H，et al. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes[J]. British Journal of Pharmacology，1997，120（5）： 968-974.
[22] CZEKALLA J，BEASLEY C J，DELLVA M A，et al. Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis[J]. Journal of Clinical Psychiatry，2001，62（3）： 191-198.
[23] SALVO F，PARIENTE A，SHAKIR S，et al. Sudden cardiac and sudden unexpected death related to antipsychotics： A meta-analysis of observational studies[J]. Clinical Pharmacology and Therapeutics，2016，99（3）： 306-314.
[24] ABDEL-WAHAB B A，METWALLY M E，EL-KHAWAN-KI M M，et al. Protective effect of captopril against clozapine-induced myocarditis in rats： Role of oxidative stress，proinflammatory cytokines and DNA damage[J]. Chemico-Biological Interactions，2014，216： 43-52.
[25] GULAC P，ARNOLD M，GRMAN M，et al. Olanzapine-mediated cardiotoxicity is associated with altered energy metabolism in isolated rat hearts[J]. Acta Biochimica Polonica，2020，67（1）： 15-23.
[26] GÖTHERT M，THIES F K，VETH N. Effects of droperidol on cardiovascular adrenoceptors[J]. Archives Internationales de Pharmacodynamie et de Thérapie，1976，224（2）： 199-214.
[27] MINZENBERG M J，YOON J H. An index of relative central alpha-adrenergic receptor antagonism by antipsychotic medications[J]. Experimental and Clinical Psychopharmacology，2011，19（1）： 31-39.
[28] SPIVAK B，ROITMAN S，VERED Y，et al. Diminished suicidal and aggressive behavior，high plasma norepinephrine levels，and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine[J]. Clinical Neuropharmacology，1998，21（4）： 245-250.
[29] BOYDA H N，HO A A，TSE L，et al. Differential effects of acute treatment with antipsychotic drugs on peripheral catecholamines[J]. Frontiers in Psychiatry，2020，11： 617428.
[30] WANG J F，MIN J Y，HAMPTON T G，et al. Clozapine-induced myocarditis： Role of catecholamines in a murine model[J]. European Journal of Pharmacology，2008，592（1/2/3）： 123-127.
[31] LI L L，GAO P，TANG X R，et al. CB1R-stabilized NLRP3 inflammasome drives antipsychotics cardiotoxicity[J]. Signal Transduction and Targeted Therapy，2022，7（1）： 190.
[32] WANG J，LI X Q，LIU Z，et al. Second-generation antipsychotics induce cardiotoxicity by disrupting spliceosome signaling： Implications from proteomic and transcriptomic analyses[J]. Pharmacological Research，2021，170： 105714.
[33] LI L L，DONG X R，TU C Y，et al. Opposite effects of cannabinoid CB1 and CB2 receptors on antipsychotic clozapine-induced cardiotoxicity[J]. British Journal of Pharmacology，2019，176（7）： 890-905.
[34] LI X Q，PENG Z，ZHOU Y L，et al. Quetiapine induces myocardial necroptotic cell death through bidirectional regulation of cannabinoid receptors[J]. Toxicology Letters，2019，313： 77-90.
[35] CHOW V，REDDEL C，PENNINGS G，et al. Global hypercoagulability in patients with schizophrenia receiving long-term antipsychotic therapy[J]. Schizophrenia Research，2015，162（1/2/3）： 175-182.
[36] D’ERRICO S，RUSSA R，MAIESE A，et al. Atypical antipsychotics and oxidative cardiotoxicity： review of literature and future perspectives to prevent sudden cardiac death[J]. Journal of Geriatric Cardiology，2021，18（8）： 663-685.
[37] 杜慧娟. 60例住院精神病患者合并心血管疾病的相关研究[J]. 中国民康医学，2013，25（6）： 73-74.
[38] CUI X，GOOCH H，GROVES N J，et al. Vitamin D and the brain： key questions for future research[J]. The Journal of Steroid Biochemistry and Molecular Biology，2015，148： 305-309.
[39] DINAN T，HOLT R，KOHEN D，et al. ‘Schizophrenia and diabetes 2003’expert consensus meeting，Dublin，3-4 October 2003： Consensus summary[J]. The British Journal of Psychiatry，2004，47： S112-S114.
[40] BATELAAN N M，SELDENRIJK A，BOT M，et al. Anxiety and new onset of cardiovascular disease： critical review and meta-analysis[J]. British Journal of Psychiatry，2016，208（3）： 223-231.
[41] SMITH K J，DESCHENES S S，SCHMITZ N. Investigating the longitudinal association between diabetes and anxiety：A systematic review and meta-analysis[J]. Diabetic Medicine，2018，35（6）： 677-693.
[42] GAO J，WANG H，LIU Y，et al. Glutamate and GABA imbalance promotes neuronal apoptosis in hippocampus after stress[J]. Medical Science Monitor，2014，20： 499-512.
[43] TSE Y C，NATH M，LAROSA A，et al. Opposing changes in synaptic and extrasynaptic N-methyl-D-aspartate receptor function in response to acute and chronic restraint stress[J]. Frontiers in Molecular Neuroscience，2021，14： 716675.
[44] LAMPERT R. Mental stress and ventricular arrhythmias[J]. Current Cardiology Reports，2016，18（12）： 118.
[45] TAGGART P，CRITCHLEY H，VAN DUIJVENDODEN S，et al. Significance of neuro-cardiac control mechanisms governed by higher regions of the brain[J]. Autonomic Neuroscience，2016，199： 54-65.
[46] LOPEZ-MEDINA A I，CHAHAL C，LUZUM J A. The genetics of drug-induced QT prolongation：Evaluating the evidence for pharmacodynamic variants[J]. Pharmacogenomics，2022，23（9）：543-557.
[47] HUERTAS-VAZQUEZ A，TEODORESCU C，REINIER K，et al. A common missense variant in the neuregulin 1 gene is associated with both schizophrenia and sudden cardiac death[J]. Heart Rhythm，2013，10（7）：994-998.
[48] VOHRA J. Sudden cardiac death in schizophrenia：A review[J]. Heart，Lung & Circulation，2020，29（10）：1427-1432.
[49] ABBOTT G W，SESTI F，SPLAWSKI I，et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia[J]. Cell，1999，97（2）：175-187.
[50] RASTOGI A，VIANI-WALSH D，AKBARI S，et al. Pathogenesis and management of Brugada syndrome in schizophrenia：A scoping review[J]. General Hospital Psychiatry，2020，67：83-91.
[51] SICOURI S，ANTZELEVITCH C. Sudden cardiac death secondary to antidepressant and antipsychotic drugs[J]. Expert Opinion on Drug Safety，2008，7（2）：181-194.
[52] ONO M，BURGESS D E，SCHRODER E A，et al. Long QT syndrome type 2：emerging strategies for correcting class 2 KCNH2 （hERG） mutations and identifying new patients[J]. Biomolecules，2020，10（8）：1-15.
[53] TAN H L，ALINGS M，VAN OLDEN R W，et al. Long-term （subacute） potassium treatment in congenital HERG-related long QT syndrome （LQTS2）[J]. Journal of Cardiovascular Electrophysiology，1999，10（2）：229-233.
[54] MONASKY M M，PAPPONE C，PICCOLI M，et al. Calcium in brugada syndrome：questions for future resear-ch[J]. Frontiers in Physiology，2018，9：1088.
[55] WILDE A，AMIN A S. Clinical Spectrum of SCN5A Mutations：Long QT syndrome，Brugada syndrome， and cardiomyopathy[J]. JACC Clinical Electrophysiology，2018，4（5）：569-579.
[56] PEREZ-RIERA A R，BARBOSA-BARROS R，DAMINE-LLO R R，et al. The congenital long QT syndrome type 3：An update[J]. Indian Pacing and Electrophysiology Journal，2018，18（1）：25-35.
[57] CHRISTIANSEN S L，ANDERSEN J D，THEMUDO G E，et al. Genetic investigations of 100 inherited cardiac disease-related genes in deceased individuals with schizophrenia[J]. International Journal of Legal Medicine，2021，135（4）：1395-1405.
[58] 田英汉，夏磊，杨铖，等. 抗精神病药致心源性猝死机制及临床预防[J]. 安徽预防医学杂志，2022，28（5）：352-356.
[59] ZHANG M L，WANG S Y，TANG X R，et al. Use of potassium ion channel and spliceosome proteins as diagnostic biomarkers for sudden unexplained death in schizophrenia[J]. Forensic Science International，2022，340：111471.